Brevan Howard Capital Management LP Iovance Biotherapeutics, Inc. Transaction History
Brevan Howard Capital Management LP
- $14.2 Billion
- Q3 2024
A detailed history of Brevan Howard Capital Management LP transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 34,121 shares of IOVA stock, worth $251,812. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,121
Previous 23,771
43.54%
Holding current value
$251,812
Previous $190,000
68.42%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding IOVA
# of Institutions
313Shares Held
237MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$202 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$196 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$177 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$157 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$97.4 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.16B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...